XT
ENTX icon

XTX Topco’s Entera Bio ENTX Stock Holding History

XTX Topco’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4K Sell
20,559
-111,063
-84% -$139K ﹤0.01% 3786
2026
Q1 		$146K Buy
+131,622
New +$185K ﹤0.01% 2967
2025
Q4 		– Sell
-10,771
Closed -$20.7K – 3432
2025
Q3 		$20.7K Buy
+10,771
New +$20.6K ﹤0.01% 2326
2025
Q2 		– Sell
-10,859
Closed -$18.5K – 2565
2025
Q1 		$18.5K Buy
+10,859
New +$23.6K ﹤0.01% 2153
2021
Q3 		– Sell
-10,433
Closed -$62K – 772
2021
Q2 		$62K Sell
10,433
-1,126
-10% -$4.16K 0.02% 713
2021
Q1 		$44K Buy
+11,559
New +$26.6K 0.02% 629

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

XTX Topco's ENTX Position: Q2 2026 in Review

XTX Topco reduced its Entera Bio (ENTX) stake by 84% in Q2 2026, selling an estimated $139K and leaving 20,559 shares worth $36.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3786.

XTX Topco first reported a position in ENTX in Q1 2021 and has held it in 6 quarters since. The position peaked at $146K in Q1 2026. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • XTX Topco held 20,559 shares of Entera Bio worth $36.4K as of Q2 2026.
  • XTX Topco sold 111,063 Entera Bio shares in Q2 2026, an estimated $139K.
  • Entera Bio made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3786 holding.
  • XTX Topco first reported a position in Entera Bio in Q1 2021 and has held it in 6 quarters since.
  • XTX Topco's Entera Bio position peaked at $146K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.